News
Ionis and Arrowhead Pharma showcase new data with their apoC-III-blocking drugs in rare disease FCS and hypertriglyceridaemia at ACC24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback